Project EASI-Genomics (funded activity)

EASIGenomics-Logo150x108

Characterisation of genetic determinants of severity in SARS-CoV-2 infection (COVID-19)

EASI-Genomics is a consortium, bringing together several of the most important genomic centres at European level, whose mission is to provide easy access to state-of-the-art DNA sequencing technologies to researchers in academia and industry, within a framework that ensures compliance with ethical and legal requirements, as well as secure and fair data management.

This funded activity is part of a internal call for proposals launched by EASI-Genomics to study DNA and RNA sequencing in human patients from low risk populations with severe forms of SARS-Cov2 infection who have experienced adverse reactions or fatal outcomes.

To carry out this study, 150 samples were examined from individuals affected by SARS-Cov2 with a severe diagnostic picture who are under 60 years of age and without any family relationship. Using bioinformatics tools and using the information available from UK Biobank as a reference, the genes involved in the clinical development of severe forms of Covid-19 were identified.

Granted to: Universidad Internacional de La Rioja (UNIR)

UNIR teams: Faculty of Health

The root project is funded by the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No. 824110.

More information:

https://www.easi-genomics.eu/

 

logo-ce-horizontal-en-pantone-lr